Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles & Nanoparticle Therapeutics Europe 2022

Jelle Penders's Biography



Jelle Penders, CEO & CTO, SPARTA Biodiscovery Ltd.

Dr. Jelle Penders is the CEO/CTO and co-founder of SPARTA Biodiscovery Ltd. a new spin-out from the Stevens Group from Prof. Molly Stevens FRS FREng at Imperial College London. He is co-inventor of the SPARTA® technology (Single Particle Automated Raman Trapping Analysis) which is a novel analytical modality designed for nanoparticle and nanoformulation analysis with widespread applications from pharmaceuticals to cancer diagnostics. His research focuses on the development and application of advanced characterisation methods for nanomaterials and nanoformulations with core expertise in Raman spectroscopy, Electron Microscopy and Exosomes. He holds a PhD from Imperial College London at the interface of Materials and Bioengineering, a MSc from Chalmers University of Technology, Sweden in Materials Chemistry and Nanotechnology and a BSc in Chemistry and Chemical Engineering from the Eindhoven University of Technology, The Netherlands.

Jelle Penders Image

SPARTA® - Enabling Nanoformulations For Next-Generation Therapeutics

Tuesday, 25 October 2022 at 09:45

Add to Calendar ▼2022-10-25 09:45:002022-10-25 10:45:00Europe/LondonSPARTA® - Enabling Nanoformulations For Next-Generation TherapeuticsExtracellular Vesicles and Nanoparticle Therapeutics Europe 2022 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

SPARTA® (Single Particle Automated Raman Trapping Analysis) is a cutting-edge benchtop instrument that chemically analyses and characterizes single nanoparticles in a fully automated, high-throughput, non-destructive label-free process. Dr. Penders will talk through the benefits of this technique for nanoformulation research as well as industry applications and show the breath of data that can be acquired and analyzed.


Add to Calendar ▼2022-10-24 00:00:002022-10-25 00:00:00Europe/LondonExtracellular Vesicles and Nanoparticle Therapeutics Europe 2022Extracellular Vesicles and Nanoparticle Therapeutics Europe 2022 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com